Abstract
Synbiotics aim to improve gastrointestinal health by combining pre- and probiotics. This study evaluated combinations of Bifidobacterium animalis subsp. lactis BB-12 with seven fructans: oligofructoses (OF1-OF2; low degree of polymerization (DP)), inulins (IN1-IN2-IN3; high DP) and OF/IN mixtures (OF/IN1-OF/IN2). During monoculture incubations, all fructans were fermented by BB-12 as followed from increased BB-12 numbers and increased acetate and lactate concentrations, with most pronounced fermentation for low DP fructans (OF1-OF2). Further, short-term colonic incubations for three human donors revealed that also in presence of a complex microbiota, all fructans (particularly OF1) consistently selectively enhanced the growth of BB-12. While each fructan as such already increased Bifidobacteriaceae numbers with 0.94–1.26 log(cells/mL), BB-12 co-supplementation additionally increased Bifidobacteriaceae with 0.17–0.46 log(cells/mL). Further, when co-supplemented with fructans, BB-12 decreased Enterobacteriaceae numbers (significant except for IN1-IN3). At metabolic level, all fructans decreased pH due to increased acetate and lactate production, while OF/IN2-IN1-IN2-IN3 also stimulated propionate and butyrate production. BB-12 co-supplementation further increased propionate and butyrate for OF/IN2-IN3 and IN1-IN2, respectively. Overall, combinations of BB-12 with fructans are promising synbiotic concepts, likely due to intracellular consumption of low DP-fructans by BB-12 (either present in starting product or released upon fermentation by indigenous microbes), thereby enhancing effects of the co-administered fructan.
Highlights
During the past decade, pre, pro- and synbiotics have been extensively studied with the aim to improve gastrointestinal health
Potential fermentation of seven fructan-type carbohydrates by BB-12 was investigated in monoculture incubations with focus on endpoints related to microbial metabolic activity and growth of BB-12
Propionate, butyrate, branched SCFA (bCFA) and gas were not produced in the synbiotic incubations, which is in line with the inability of BB-12 to produce gas and these metabolites, confirming sterility of the faecal suspensions
Summary
Pre-, pro- and synbiotics have been extensively studied with the aim to improve gastrointestinal health. This screening involved in vitro incubations to: (i) confirm intrinsic capacity of BB-12 to grow in presence of sterile fecal suspension of a given donor, as well as (ii) to assess the diversity of the overall metabolic activity of the fecal microbiota of each donor (experiment 2) short-term colonic incubations were performed to assess the synbiotic potential of the fructan-type carbohydrates combined with BB-12 in presence of the complex microbiota derived from three selected human donors (experiment 3) During this final experiment, microbial composition was assessed using a novel technique, i.e., quantitative 16S-targeted Illumina sequencing allowing to obtain quantitative insights in microbiome modulation at high phylogenetic resolution [27].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.